Assyro AI

FDA Orange Book · active-ingredient family

Acetaminophen; propoxyphene hydrochloride

Acetaminophen; propoxyphene hydrochloride is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DARVOCET · NDA 016844

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
DARVOCETAAIPHARMA LLCNDA 016844Approved Prior to Jan 1, 1982

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENVINTAGE PHARMSANDA 040507Jul 30, 2003
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENWATSON LABSANDA 040139Dec 16, 1996
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENSANDOZANDA 089959Jul 18, 1989
DOLENE AP-65LEDERLEANDA 085100Approved Prior to Jan 1, 1982
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENMYLANANDA 083689Approved Prior to Jan 1, 1982
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENMYLANANDA 083978Approved Prior to Jan 1, 1982
WYGESICCARACOANDA 084999Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Acetaminophen; propoxyphene hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.